Global Organ On Chip Market Growth (Status and Outlook) 2026-2032

October 2026 | 146 pages | ID: GF47CCEC2505EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Organ On Chip market size is predicted to grow from US$ 216 million in 2025 to US$ 1410 million in 2032; it is expected to grow at a CAGR of 31.3% from 2026 to 2032.

A Organ on Chip is a small-scale device that replicates the mechanical and biological properties of human organs. These chips contain tiny channels lined with living human cells that form tissue layers. They can simulate the physiology of various organs, such as the heart, liver, lungs, kidneys, and intestines, allowing researchers to better understand organ-specific functions and diseases. These models are typically made using microfluidic technology, where human cells are cultured in a small, transparent chip, allowing researchers to simulate organ-specific functions and study disease processes, drug responses, and more. By offering more accurate, scalable, and human-relevant data, Human Organs-on-Chips are revolutionizing biomedical research and drug testing, providing a bridge between traditional animal models and human clinical trials.The price of Organ-on-Chip products varies significantly depending on chip architecture, number of microfluidic channels, integration of perfusion or sensing functions, and automation level. In 2025–2026, basic microfluidic organ-on-chip devices are generally priced at around US$20–100 per chip, while multi-well or high-throughput chip plates are typically about US$80–500 per plate. Supporting pumps, controllers, and culture modules usually cost approximately US$3,000–20,000 per system, while fully integrated and automated organ-on-chip platforms may exceed US$20,000–100,000 per system.

The upstream value chain mainly includes chip substrate materials such as PDMS, COP/COC, and glass, together with porous membranes, ECM/hydrogels, cells, culture media, sensors, and microfluidic components. Midstream companies such as Emulate, MIMETAS, TissUse, CN Bio, and AIM Biotech are responsible for microfluidic chip design, manufacturing, and integration of culture and perfusion systems. Downstream users mainly include pharmaceutical and biotechnology companies, CROs, academic and research institutions, and regulatory science organizations. Organ-on-chip platforms are primarily used for drug screening, ADME/DMPK studies, toxicology assessment, disease modeling, precision medicine, and the reduction or replacement of animal testing.

Market Drivers

Regulatory Support for Reducing Animal Testing

Global drug development regulations are increasingly encouraging the adoption of non-animal testing methods. Organ-on-chip systems can use human-derived cells to reproduce organ-specific microenvironments and physiological functions, offering stronger human relevance for drug safety, toxicology, and efficacy assessment. Continued support from regulatory and research organizations such as the FDA, NIH, and European institutions is accelerating the adoption and commercialization of microphysiological systems and organ-on-chip technologies.

Growing Demand to Improve Pharmaceutical R&D Efficiency

Traditional two-dimensional cell cultures and animal models have limitations in predicting human drug responses. Organ-on-chip platforms combine three-dimensional cell culture, microfluidics, dynamic perfusion, and multicellular co-culture to better reproduce human tissue environments. As drug development costs continue to rise, pharmaceutical companies are increasingly using organ-on-chip systems for candidate screening, ADME/DMPK studies, toxicity testing, and disease modeling.

Increasing Demand for Precision Medicine and Human-Relevant Disease Models

Organ-on-chip technologies can be integrated with patient-derived cells, induced pluripotent stem cells, organoids, and gene-editing technologies to create human-relevant models with specific genetic and disease characteristics. Growing demand for precision treatment in oncology, neurological disorders, rare diseases, and metabolic diseases is expanding the application of organ-on-chip systems in personalized drug screening, disease mechanism research, and patient stratification.

Market Restraints

Relatively High Equipment and Experimental Costs

Organ-on-chip experiments often require microfluidic chips, specialized culture media, extracellular matrices, hydrogels, pumping systems, sensors, and imaging equipment. Overall experimental costs are generally higher than conventional two-dimensional cell culture and standard microplate assays. Integrated and automated organ-on-chip platforms also require relatively high initial capital investment, which can limit adoption among small laboratories and research institutions with restricted budgets.

Limited Standardization Across Platforms

Organ-on-chip manufacturers use different chip materials, channel geometries, membranes, cell sources, culture conditions, flow rates, and analytical methods. The industry has not yet established fully standardized technical specifications and evaluation systems. Differences among platforms may reduce inter-laboratory reproducibility and data comparability, creating barriers to broader adoption in standardized pharmaceutical development and regulatory assessment.

Constraints in High-Quality Cell Sources and Long-Term Culture

The performance of organ-on-chip systems strongly depends on the quality of primary cells, stem-cell-derived cells, and other human-derived biological materials. Some organ-specific cell types remain difficult to obtain and may exhibit batch-to-batch variability, phenotype instability, or limited long-term viability. Variability in cellular materials can directly affect experimental consistency and complicate large-scale deployment and standardized validation.Market Opportunities

Expanding Applications in Drug Safety and Toxicology Assessment

Organ-on-chip platforms have significant potential in drug-induced liver injury, cardiotoxicity, nephrotoxicity, pulmonary toxicity, and blood-brain barrier studies. As regulatory authorities gradually increase acceptance of human-relevant alternative models, organ-on-chip systems are expected to move beyond academic research and become increasingly integrated into preclinical safety assessment workflows, creating strong opportunities for liver-on-chip, heart-on-chip, kidney-on-chip, and related platforms.

Development of High-Throughput and Automated Platforms

The industry is moving from individual microfluidic devices toward multi-well-compatible, high-throughput, and automated systems. These platforms are increasingly integrated with automated liquid handling, high-content imaging, real-time biosensors, and AI-based data analysis. High-throughput systems can reduce per-test costs, improve reproducibility, and facilitate integration into existing pharmaceutical screening workflows, supporting growth in both consumable chips and supporting instruments.

Strong Potential for Multi-Organ and Body-on-Chip Systems

Multi-organ platforms can connect liver, intestine, kidney, heart, and other tissue models to investigate drug absorption, distribution, metabolism, excretion, and organ-to-organ interactions. As microfluidic control, long-term culture, and multi-organ coupling technologies continue to improve, these systems are expected to gain wider use in systemic toxicology, PK/PD analysis, and complex disease modeling, creating new high-value market segments.

Market Challenges

Balancing Physiological Relevance with Throughput

Organ-on-chip systems rely on multicellular co-culture, three-dimensional extracellular matrices, mechanical stimulation, dynamic fluid flow, and sensing technologies to improve physiological relevance. However, greater biological complexity generally increases manufacturing costs, operational difficulty, and experimental failure risks. Achieving an effective balance among model complexity, reproducibility, throughput, cost, and ease of use remains a major technical challenge for large-scale commercialization.

Regulatory Acceptance Requires Extensive Validation

Although regulatory authorities are showing increasing interest in organ-on-chip and microphysiological systems, replacing conventional animal testing or using these platforms for formal regulatory decision-making still requires extensive inter-laboratory validation, reference-compound testing, and comparison with clinical data. Different organ models may progress through validation and regulatory acceptance at different speeds, potentially slowing commercial adoption.

Competition Among Multiple Technology Platforms

The market includes membrane-based, membrane-free, ECM-based microfluidic, multi-well plate, pump-driven, and gravity-driven organ-on-chip architectures. Each platform has different advantages in physiological relevance, throughput, operational complexity, and cost. Uncertainty over which technologies will ultimately become widely accepted by pharmaceutical companies and regulatory authorities increases R&D risks for manufacturers and platform-selection risks for customers.

Report Scope

LPI (LP Information)' newest research report, the “Organ On Chip Industry Forecast” looks at past sales and reviews total world Organ On Chip sales in 2025, providing a comprehensive analysis by region and market sector of projected Organ On Chip sales for 2026 through 2032. With Organ On Chip sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Organ On Chip industry.

This Insight Report provides a comprehensive analysis of the global Organ On Chip landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Organ On Chip portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Organ On Chip market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Organ On Chip and breaks down the forecast by Type, by End User, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Organ On Chip.

This report presents a comprehensive overview, market shares, and growth opportunities of Organ On Chip market by product type, application, key players and key regions and countries.

Market Segmentation

Segmentation by Type:

  • Brain-on-a-chip
  • Liver-on-a-chip
  • Kidney-on-a-chip
  • Lung-on-a-chip
  • Heart-on-a-chip
  • Intestine-on-a-chip
  • Vessel-on-a-chip
  • Other Organs

Segmentation by System Integration:

  • Single-organ-on-Chip
  • Multi-organ-on-Chip

Segmentation by Chip Structure:

  • Membrane-based Organ-on-Chip
  • Membrane-free Organ-on-Chip

Segmentation by End User:

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Cosmetics Industry
  • Others

This report also splits the market by region:

  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Emulate
  • MIMETAS
  • TissUse
  • CN Bio Innovations
  • AIM Biotech
  • AlveoliX
  • Beonchip
  • React4life
  • InSphero
  • NETRI
  • SynVivo
  • BiomimX
  • Dynamic42
  • Kirkstall
  • Cherry Biotech
  • Micronit
  • Cellbox Labs
  • REVIVO BioSystems
  • MesoBioTech
  • Beijing Daxiang Biotech
  • AVATARGET
  • Suzhou Jiyan Biopharmaceutical
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Organ On Chip Market Size (2021-2032)
  2.1.2 Organ On Chip Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Organ On Chip by Country/Region (2021, 2025 & 2032)
2.2 Organ On Chip Segment by Type
  2.2.1 Brain-on-a-chip
  2.2.2 Liver-on-a-chip
  2.2.3 Kidney-on-a-chip
  2.2.4 Lung-on-a-chip
  2.2.5 Heart-on-a-chip
  2.2.6 Intestine-on-a-chip
  2.2.7 Vessel-on-a-chip
  2.2.8 Other Organs
  2.2.9 Organ On Chip Market Size by Type
    2.2.9.1 Organ On Chip Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.9.2 Global Organ On Chip Market Size Market Share by Type (2021-2026)
2.3 Organ On Chip Segment by System Integration
  2.3.1 Single-organ-on-Chip
  2.3.2 Multi-organ-on-Chip
  2.3.3 Organ On Chip Market Size by System Integration
    2.3.3.1 Organ On Chip Market Size CAGR by System Integration (2021 VS 2025 VS 2032)
    2.3.3.2 Global Organ On Chip Market Size Market Share by System Integration (2021-2026)
2.4 Organ On Chip Segment by Chip Structure
  2.4.1 Membrane-based Organ-on-Chip
  2.4.2 Membrane-free Organ-on-Chip
  2.4.3 Organ On Chip Market Size by Chip Structure
    2.4.3.1 Organ On Chip Market Size CAGR by Chip Structure (2021 VS 2025 VS 2032)
    2.4.3.2 Global Organ On Chip Market Size Market Share by Chip Structure (2021-2026)
2.5 Organ On Chip Segment by End User
  2.5.1 Pharmaceutical & Biotechnology Companies
  2.5.2 Academic & Research Institutes
  2.5.3 Cosmetics Industry
  2.5.4 Others
  2.5.5 Organ On Chip Market Size by End User
    2.5.5.1 Organ On Chip Market Size CAGR by End User (2021 VS 2025 VS 2032)
    2.5.5.2 Global Organ On Chip Market Size Market Share by End User (2021-2026)

3 ORGAN ON CHIP MARKET SIZE BY PLAYER

3.1 Organ On Chip Market Size Market Share by Player
  3.1.1 Global Organ On Chip Revenue by Player (2021-2026)
  3.1.2 Global Organ On Chip Revenue Market Share by Player (2021-2026)
3.2 Global Organ On Chip Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ORGAN ON CHIP BY REGION

4.1 Organ On Chip Market Size by Region (2021-2026)
4.2 Global Organ On Chip Annual Revenue by Country/Region (2021-2026)
4.3 Americas Organ On Chip Market Size Growth (2021-2026)
4.4 APAC Organ On Chip Market Size Growth (2021-2026)
4.5 Europe Organ On Chip Market Size Growth (2021-2026)
4.6 Middle East & Africa Organ On Chip Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Organ On Chip Market Size by Country (2021-2026)
5.2 Americas Organ On Chip Market Size by Type (2021-2026)
5.3 Americas Organ On Chip Market Size by End User (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Organ On Chip Market Size by Region (2021-2026)
6.2 APAC Organ On Chip Market Size by Type (2021-2026)
6.3 APAC Organ On Chip Market Size by End User (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Organ On Chip Market Size by Country (2021-2026)
7.2 Europe Organ On Chip Market Size by Type (2021-2026)
7.3 Europe Organ On Chip Market Size by End User (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Organ On Chip by Region (2021-2026)
8.2 Middle East & Africa Organ On Chip Market Size by Type (2021-2026)
8.3 Middle East & Africa Organ On Chip Market Size by End User (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL ORGAN ON CHIP MARKET FORECAST

10.1 Global Organ On Chip Forecast by Region (2027-2032)
  10.1.1 Global Organ On Chip Forecast by Region (2027-2032)
  10.1.2 Americas Organ On Chip Forecast
  10.1.3 APAC Organ On Chip Forecast
  10.1.4 Europe Organ On Chip Forecast
  10.1.5 Middle East & Africa Organ On Chip Forecast
10.2 Americas Organ On Chip Forecast by Country (2027-2032)
  10.2.1 United States Market Organ On Chip Forecast
  10.2.2 Canada Market Organ On Chip Forecast
  10.2.3 Mexico Market Organ On Chip Forecast
  10.2.4 Brazil Market Organ On Chip Forecast
10.3 APAC Organ On Chip Forecast by Region (2027-2032)
  10.3.1 China Organ On Chip Market Forecast
  10.3.2 Japan Market Organ On Chip Forecast
  10.3.3 Korea Market Organ On Chip Forecast
  10.3.4 Southeast Asia Market Organ On Chip Forecast
  10.3.5 India Market Organ On Chip Forecast
  10.3.6 Australia Market Organ On Chip Forecast
10.4 Europe Organ On Chip Forecast by Country (2027-2032)
  10.4.1 Germany Market Organ On Chip Forecast
  10.4.2 France Market Organ On Chip Forecast
  10.4.3 UK Market Organ On Chip Forecast
  10.4.4 Italy Market Organ On Chip Forecast
  10.4.5 Russia Market Organ On Chip Forecast
10.5 Middle East & Africa Organ On Chip Forecast by Region (2027-2032)
  10.5.1 Egypt Market Organ On Chip Forecast
  10.5.2 South Africa Market Organ On Chip Forecast
  10.5.3 Israel Market Organ On Chip Forecast
  10.5.4 Turkey Market Organ On Chip Forecast
10.6 Global Organ On Chip Forecast by Type (2027-2032)
10.7 Global Organ On Chip Forecast by End User (2027-2032)
  10.7.1 GCC Countries Market Organ On Chip Forecast

11 KEY PLAYERS ANALYSIS

11.1 Emulate
  11.1.1 Emulate Company Information
  11.1.2 Emulate Organ On Chip Product Offered
  11.1.3 Emulate Organ On Chip Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 Emulate Main Business Overview
  11.1.5 Emulate Latest Developments
11.2 MIMETAS
  11.2.1 MIMETAS Company Information
  11.2.2 MIMETAS Organ On Chip Product Offered
  11.2.3 MIMETAS Organ On Chip Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 MIMETAS Main Business Overview
  11.2.5 MIMETAS Latest Developments
11.3 TissUse
  11.3.1 TissUse Company Information
  11.3.2 TissUse Organ On Chip Product Offered
  11.3.3 TissUse Organ On Chip Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 TissUse Main Business Overview
  11.3.5 TissUse Latest Developments
11.4 CN Bio Innovations
  11.4.1 CN Bio Innovations Company Information
  11.4.2 CN Bio Innovations Organ On Chip Product Offered
  11.4.3 CN Bio Innovations Organ On Chip Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 CN Bio Innovations Main Business Overview
  11.4.5 CN Bio Innovations Latest Developments
11.5 AIM Biotech
  11.5.1 AIM Biotech Company Information
  11.5.2 AIM Biotech Organ On Chip Product Offered
  11.5.3 AIM Biotech Organ On Chip Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 AIM Biotech Main Business Overview
  11.5.5 AIM Biotech Latest Developments
11.6 AlveoliX
  11.6.1 AlveoliX Company Information
  11.6.2 AlveoliX Organ On Chip Product Offered
  11.6.3 AlveoliX Organ On Chip Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 AlveoliX Main Business Overview
  11.6.5 AlveoliX Latest Developments
11.7 Beonchip
  11.7.1 Beonchip Company Information
  11.7.2 Beonchip Organ On Chip Product Offered
  11.7.3 Beonchip Organ On Chip Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 Beonchip Main Business Overview
  11.7.5 Beonchip Latest Developments
11.8 React4life
  11.8.1 React4life Company Information
  11.8.2 React4life Organ On Chip Product Offered
  11.8.3 React4life Organ On Chip Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 React4life Main Business Overview
  11.8.5 React4life Latest Developments
11.9 InSphero
  11.9.1 InSphero Company Information
  11.9.2 InSphero Organ On Chip Product Offered
  11.9.3 InSphero Organ On Chip Revenue, Gross Margin and Market Share (2021-2026)
  11.9.4 InSphero Main Business Overview
  11.9.5 InSphero Latest Developments
11.10 NETRI
  11.10.1 NETRI Company Information
  11.10.2 NETRI Organ On Chip Product Offered
  11.10.3 NETRI Organ On Chip Revenue, Gross Margin and Market Share (2021-2026)
  11.10.4 NETRI Main Business Overview
  11.10.5 NETRI Latest Developments
11.11 SynVivo
  11.11.1 SynVivo Company Information
  11.11.2 SynVivo Organ On Chip Product Offered
  11.11.3 SynVivo Organ On Chip Revenue, Gross Margin and Market Share (2021-2026)
  11.11.4 SynVivo Main Business Overview
  11.11.5 SynVivo Latest Developments
11.12 BiomimX
  11.12.1 BiomimX Company Information
  11.12.2 BiomimX Organ On Chip Product Offered
  11.12.3 BiomimX Organ On Chip Revenue, Gross Margin and Market Share (2021-2026)
  11.12.4 BiomimX Main Business Overview
  11.12.5 BiomimX Latest Developments
11.13 Dynamic42
  11.13.1 Dynamic42 Company Information
  11.13.2 Dynamic42 Organ On Chip Product Offered
  11.13.3 Dynamic42 Organ On Chip Revenue, Gross Margin and Market Share (2021-2026)
  11.13.4 Dynamic42 Main Business Overview
  11.13.5 Dynamic42 Latest Developments
11.14 Kirkstall
  11.14.1 Kirkstall Company Information
  11.14.2 Kirkstall Organ On Chip Product Offered
  11.14.3 Kirkstall Organ On Chip Revenue, Gross Margin and Market Share (2021-2026)
  11.14.4 Kirkstall Main Business Overview
  11.14.5 Kirkstall Latest Developments
11.15 Cherry Biotech
  11.15.1 Cherry Biotech Company Information
  11.15.2 Cherry Biotech Organ On Chip Product Offered
  11.15.3 Cherry Biotech Organ On Chip Revenue, Gross Margin and Market Share (2021-2026)
  11.15.4 Cherry Biotech Main Business Overview
  11.15.5 Cherry Biotech Latest Developments
11.16 Micronit
  11.16.1 Micronit Company Information
  11.16.2 Micronit Organ On Chip Product Offered
  11.16.3 Micronit Organ On Chip Revenue, Gross Margin and Market Share (2021-2026)
  11.16.4 Micronit Main Business Overview
  11.16.5 Micronit Latest Developments
11.17 Cellbox Labs
  11.17.1 Cellbox Labs Company Information
  11.17.2 Cellbox Labs Organ On Chip Product Offered
  11.17.3 Cellbox Labs Organ On Chip Revenue, Gross Margin and Market Share (2021-2026)
  11.17.4 Cellbox Labs Main Business Overview
  11.17.5 Cellbox Labs Latest Developments
11.18 REVIVO BioSystems
  11.18.1 REVIVO BioSystems Company Information
  11.18.2 REVIVO BioSystems Organ On Chip Product Offered
  11.18.3 REVIVO BioSystems Organ On Chip Revenue, Gross Margin and Market Share (2021-2026)
  11.18.4 REVIVO BioSystems Main Business Overview
  11.18.5 REVIVO BioSystems Latest Developments
11.19 MesoBioTech
  11.19.1 MesoBioTech Company Information
  11.19.2 MesoBioTech Organ On Chip Product Offered
  11.19.3 MesoBioTech Organ On Chip Revenue, Gross Margin and Market Share (2021-2026)
  11.19.4 MesoBioTech Main Business Overview
  11.19.5 MesoBioTech Latest Developments
11.20 Beijing Daxiang Biotech
  11.20.1 Beijing Daxiang Biotech Company Information
  11.20.2 Beijing Daxiang Biotech Organ On Chip Product Offered
  11.20.3 Beijing Daxiang Biotech Organ On Chip Revenue, Gross Margin and Market Share (2021-2026)
  11.20.4 Beijing Daxiang Biotech Main Business Overview
  11.20.5 Beijing Daxiang Biotech Latest Developments
11.21 AVATARGET
  11.21.1 AVATARGET Company Information
  11.21.2 AVATARGET Organ On Chip Product Offered
  11.21.3 AVATARGET Organ On Chip Revenue, Gross Margin and Market Share (2021-2026)
  11.21.4 AVATARGET Main Business Overview
  11.21.5 AVATARGET Latest Developments
11.22 Suzhou Jiyan Biopharmaceutical
  11.22.1 Suzhou Jiyan Biopharmaceutical Company Information
  11.22.2 Suzhou Jiyan Biopharmaceutical Organ On Chip Product Offered
  11.22.3 Suzhou Jiyan Biopharmaceutical Organ On Chip Revenue, Gross Margin and Market Share (2021-2026)
  11.22.4 Suzhou Jiyan Biopharmaceutical Main Business Overview
  11.22.5 Suzhou Jiyan Biopharmaceutical Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Organ On Chip Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Organ On Chip Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Brain-on-a-chip
Table 4. Major Players of Liver-on-a-chip
Table 5. Major Players of Kidney-on-a-chip
Table 6. Major Players of Lung-on-a-chip
Table 7. Major Players of Heart-on-a-chip
Table 8. Major Players of Intestine-on-a-chip
Table 9. Major Players of Vessel-on-a-chip
Table 10. Major Players of Other Organs
Table 11. Organ On Chip Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global Organ On Chip Market Size by Type (2021-2026) & ($ millions)
Table 13. Global Organ On Chip Market Size Market Share by Type (2021-2026)
Table 14. Major Players of Single-organ-on-Chip
Table 15. Major Players of Multi-organ-on-Chip
Table 16. Organ On Chip Market Size CAGR by System Integration (2021 VS 2025 VS 2032) & ($ millions)
Table 17. Global Organ On Chip Market Size by System Integration (2021-2026) & ($ millions)
Table 18. Global Organ On Chip Market Size Market Share by System Integration (2021-2026)
Table 19. Major Players of Membrane-based Organ-on-Chip
Table 20. Major Players of Membrane-free Organ-on-Chip
Table 21. Organ On Chip Market Size CAGR by Chip Structure (2021 VS 2025 VS 2032) & ($ millions)
Table 22. Global Organ On Chip Market Size by Chip Structure (2021-2026) & ($ millions)
Table 23. Global Organ On Chip Market Size Market Share by Chip Structure (2021-2026)
Table 24. Organ On Chip Market Size CAGR by End User (2021 VS 2025 VS 2032) & ($ millions)
Table 25. Global Organ On Chip Market Size by End User (2021-2026) & ($ millions)
Table 26. Global Organ On Chip Market Size Market Share by End User (2021-2026)
Table 27. Global Organ On Chip Revenue by Player (2021-2026) & ($ millions)
Table 28. Global Organ On Chip Revenue Market Share by Player (2021-2026)
Table 29. Organ On Chip Key Players Head office and Products Offered
Table 30. Organ On Chip Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 31. New Products and Potential Entrants
Table 32. Mergers & Acquisitions, Expansion
Table 33. Global Organ On Chip Market Size by Region (2021-2026) & ($ millions)
Table 34. Global Organ On Chip Market Size Market Share by Region (2021-2026)
Table 35. Global Organ On Chip Revenue by Country/Region (2021-2026) & ($ millions)
Table 36. Global Organ On Chip Revenue Market Share by Country/Region (2021-2026)
Table 37. Americas Organ On Chip Market Size by Country (2021-2026) & ($ millions)
Table 38. Americas Organ On Chip Market Size Market Share by Country (2021-2026)
Table 39. Americas Organ On Chip Market Size by Type (2021-2026) & ($ millions)
Table 40. Americas Organ On Chip Market Size Market Share by Type (2021-2026)
Table 41. Americas Organ On Chip Market Size by End User (2021-2026) & ($ millions)
Table 42. Americas Organ On Chip Market Size Market Share by End User (2021-2026)
Table 43. APAC Organ On Chip Market Size by Region (2021-2026) & ($ millions)
Table 44. APAC Organ On Chip Market Size Market Share by Region (2021-2026)
Table 45. APAC Organ On Chip Market Size by Type (2021-2026) & ($ millions)
Table 46. APAC Organ On Chip Market Size by End User (2021-2026) & ($ millions)
Table 47. Europe Organ On Chip Market Size by Country (2021-2026) & ($ millions)
Table 48. Europe Organ On Chip Market Size Market Share by Country (2021-2026)
Table 49. Europe Organ On Chip Market Size by Type (2021-2026) & ($ millions)
Table 50. Europe Organ On Chip Market Size by End User (2021-2026) & ($ millions)
Table 51. Middle East & Africa Organ On Chip Market Size by Region (2021-2026) & ($ millions)
Table 52. Middle East & Africa Organ On Chip Market Size by Type (2021-2026) & ($ millions)
Table 53. Middle East & Africa Organ On Chip Market Size by End User (2021-2026) & ($ millions)
Table 54. Key Market Drivers & Growth Opportunities of Organ On Chip
Table 55. Key Market Challenges & Risks of Organ On Chip
Table 56. Key Industry Trends of Organ On Chip
Table 57. Global Organ On Chip Market Size Forecast by Region (2027-2032) & ($ millions)
Table 58. Global Organ On Chip Market Size Market Share Forecast by Region (2027-2032)
Table 59. Global Organ On Chip Market Size Forecast by Type (2027-2032) & ($ millions)
Table 60. Global Organ On Chip Market Size Forecast by End User (2027-2032) & ($ millions)
Table 61. Emulate Details, Company Type, Organ On Chip Area Served and Its Competitors
Table 62. Emulate Organ On Chip Product Offered
Table 63. Emulate Organ On Chip Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Emulate Main Business
Table 65. Emulate Latest Developments
Table 66. MIMETAS Details, Company Type, Organ On Chip Area Served and Its Competitors
Table 67. MIMETAS Organ On Chip Product Offered
Table 68. MIMETAS Organ On Chip Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. MIMETAS Main Business
Table 70. MIMETAS Latest Developments
Table 71. TissUse Details, Company Type, Organ On Chip Area Served and Its Competitors
Table 72. TissUse Organ On Chip Product Offered
Table 73. TissUse Organ On Chip Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. TissUse Main Business
Table 75. TissUse Latest Developments
Table 76. CN Bio Innovations Details, Company Type, Organ On Chip Area Served and Its Competitors
Table 77. CN Bio Innovations Organ On Chip Product Offered
Table 78. CN Bio Innovations Organ On Chip Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. CN Bio Innovations Main Business
Table 80. CN Bio Innovations Latest Developments
Table 81. AIM Biotech Details, Company Type, Organ On Chip Area Served and Its Competitors
Table 82. AIM Biotech Organ On Chip Product Offered
Table 83. AIM Biotech Organ On Chip Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. AIM Biotech Main Business
Table 85. AIM Biotech Latest Developments
Table 86. AlveoliX Details, Company Type, Organ On Chip Area Served and Its Competitors
Table 87. AlveoliX Organ On Chip Product Offered
Table 88. AlveoliX Organ On Chip Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. AlveoliX Main Business
Table 90. AlveoliX Latest Developments
Table 91. Beonchip Details, Company Type, Organ On Chip Area Served and Its Competitors
Table 92. Beonchip Organ On Chip Product Offered
Table 93. Beonchip Organ On Chip Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Beonchip Main Business
Table 95. Beonchip Latest Developments
Table 96. React4life Details, Company Type, Organ On Chip Area Served and Its Competitors
Table 97. React4life Organ On Chip Product Offered
Table 98. React4life Organ On Chip Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. React4life Main Business
Table 100. React4life Latest Developments
Table 101. InSphero Details, Company Type, Organ On Chip Area Served and Its Competitors
Table 102. InSphero Organ On Chip Product Offered
Table 103. InSphero Organ On Chip Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. InSphero Main Business
Table 105. InSphero Latest Developments
Table 106. NETRI Details, Company Type, Organ On Chip Area Served and Its Competitors
Table 107. NETRI Organ On Chip Product Offered
Table 108. NETRI Organ On Chip Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. NETRI Main Business
Table 110. NETRI Latest Developments
Table 111. SynVivo Details, Company Type, Organ On Chip Area Served and Its Competitors
Table 112. SynVivo Organ On Chip Product Offered
Table 113. SynVivo Organ On Chip Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. SynVivo Main Business
Table 115. SynVivo Latest Developments
Table 116. BiomimX Details, Company Type, Organ On Chip Area Served and Its Competitors
Table 117. BiomimX Organ On Chip Product Offered
Table 118. BiomimX Organ On Chip Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. BiomimX Main Business
Table 120. BiomimX Latest Developments
Table 121. Dynamic42 Details, Company Type, Organ On Chip Area Served and Its Competitors
Table 122. Dynamic42 Organ On Chip Product Offered
Table 123. Dynamic42 Organ On Chip Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. Dynamic42 Main Business
Table 125. Dynamic42 Latest Developments
Table 126. Kirkstall Details, Company Type, Organ On Chip Area Served and Its Competitors
Table 127. Kirkstall Organ On Chip Product Offered
Table 128. Kirkstall Organ On Chip Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 129. Kirkstall Main Business
Table 130. Kirkstall Latest Developments
Table 131. Cherry Biotech Details, Company Type, Organ On Chip Area Served and Its Competitors
Table 132. Cherry Biotech Organ On Chip Product Offered
Table 133. Cherry Biotech Organ On Chip Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 134. Cherry Biotech Main Business
Table 135. Cherry Biotech Latest Developments
Table 136. Micronit Details, Company Type, Organ On Chip Area Served and Its Competitors
Table 137. Micronit Organ On Chip Product Offered
Table 138. Micronit Organ On Chip Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 139. Micronit Main Business
Table 140. Micronit Latest Developments
Table 141. Cellbox Labs Details, Company Type, Organ On Chip Area Served and Its Competitors
Table 142. Cellbox Labs Organ On Chip Product Offered
Table 143. Cellbox Labs Organ On Chip Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 144. Cellbox Labs Main Business
Table 145. Cellbox Labs Latest Developments
Table 146. REVIVO BioSystems Details, Company Type, Organ On Chip Area Served and Its Competitors
Table 147. REVIVO BioSystems Organ On Chip Product Offered
Table 148. REVIVO BioSystems Organ On Chip Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 149. REVIVO BioSystems Main Business
Table 150. REVIVO BioSystems Latest Developments
Table 151. MesoBioTech Details, Company Type, Organ On Chip Area Served and Its Competitors
Table 152. MesoBioTech Organ On Chip Product Offered
Table 153. MesoBioTech Organ On Chip Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 154. MesoBioTech Main Business
Table 155. MesoBioTech Latest Developments
Table 156. Beijing Daxiang Biotech Details, Company Type, Organ On Chip Area Served and Its Competitors
Table 157. Beijing Daxiang Biotech Organ On Chip Product Offered
Table 158. Beijing Daxiang Biotech Organ On Chip Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 159. Beijing Daxiang Biotech Main Business
Table 160. Beijing Daxiang Biotech Latest Developments
Table 161. AVATARGET Details, Company Type, Organ On Chip Area Served and Its Competitors
Table 162. AVATARGET Organ On Chip Product Offered
Table 163. AVATARGET Organ On Chip Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 164. AVATARGET Main Business
Table 165. AVATARGET Latest Developments
Table 166. Suzhou Jiyan Biopharmaceutical Details, Company Type, Organ On Chip Area Served and Its Competitors
Table 167. Suzhou Jiyan Biopharmaceutical Organ On Chip Product Offered
Table 168. Suzhou Jiyan Biopharmaceutical Organ On Chip Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 169. Suzhou Jiyan Biopharmaceutical Main Business
Table 170. Suzhou Jiyan Biopharmaceutical Latest Developments

LIST OF FIGURES

Figure 1. Organ On Chip Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Organ On Chip Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Organ On Chip Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Organ On Chip Sales Market Share by Country/Region (2025)
Figure 8. Organ On Chip Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Organ On Chip Market Size Market Share by Type in 2025
Figure 10. Global Organ On Chip Market Size Market Share by System Integration in 2025
Figure 11. Global Organ On Chip Market Size Market Share by Chip Structure in 2025
Figure 12. Organ On Chip in Pharmaceutical & Biotechnology Companies
Figure 13. Global Organ On Chip Market: Pharmaceutical & Biotechnology Companies (2021-2026) & ($ millions)
Figure 14. Organ On Chip in Academic & Research Institutes
Figure 15. Global Organ On Chip Market: Academic & Research Institutes (2021-2026) & ($ millions)
Figure 16. Organ On Chip in Cosmetics Industry
Figure 17. Global Organ On Chip Market: Cosmetics Industry (2021-2026) & ($ millions)
Figure 18. Organ On Chip in Others
Figure 19. Global Organ On Chip Market: Others (2021-2026) & ($ millions)
Figure 20. Global Organ On Chip Market Size Market Share by End User in 2025
Figure 21. Global Organ On Chip Revenue Market Share by Player in 2025
Figure 22. Global Organ On Chip Market Size Market Share by Region (2021-2026)
Figure 23. Americas Organ On Chip Market Size 2021-2026 ($ millions)
Figure 24. APAC Organ On Chip Market Size 2021-2026 ($ millions)
Figure 25. Europe Organ On Chip Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa Organ On Chip Market Size 2021-2026 ($ millions)
Figure 27. Americas Organ On Chip Value Market Share by Country in 2025
Figure 28. United States Organ On Chip Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada Organ On Chip Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico Organ On Chip Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil Organ On Chip Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC Organ On Chip Market Size Market Share by Region in 2025
Figure 33. APAC Organ On Chip Market Size Market Share by Type (2021-2026)
Figure 34. APAC Organ On Chip Market Size Market Share by End User (2021-2026)
Figure 35. China Organ On Chip Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan Organ On Chip Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea Organ On Chip Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia Organ On Chip Market Size Growth 2021-2026 ($ millions)
Figure 39. India Organ On Chip Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia Organ On Chip Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe Organ On Chip Market Size Market Share by Country in 2025
Figure 42. Europe Organ On Chip Market Size Market Share by Type (2021-2026)
Figure 43. Europe Organ On Chip Market Size Market Share by End User (2021-2026)
Figure 44. Germany Organ On Chip Market Size Growth 2021-2026 ($ millions)
Figure 45. France Organ On Chip Market Size Growth 2021-2026 ($ millions)
Figure 46. UK Organ On Chip Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy Organ On Chip Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia Organ On Chip Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa Organ On Chip Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa Organ On Chip Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa Organ On Chip Market Size Market Share by End User (2021-2026)
Figure 52. Egypt Organ On Chip Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa Organ On Chip Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel Organ On Chip Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey Organ On Chip Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries Organ On Chip Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas Organ On Chip Market Size 2027-2032 ($ millions)
Figure 58. APAC Organ On Chip Market Size 2027-2032 ($ millions)
Figure 59. Europe Organ On Chip Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa Organ On Chip Market Size 2027-2032 ($ millions)
Figure 61. United States Organ On Chip Market Size 2027-2032 ($ millions)
Figure 62. Canada Organ On Chip Market Size 2027-2032 ($ millions)
Figure 63. Mexico Organ On Chip Market Size 2027-2032 ($ millions)
Figure 64. Brazil Organ On Chip Market Size 2027-2032 ($ millions)
Figure 65. China Organ On Chip Market Size 2027-2032 ($ millions)
Figure 66. Japan Organ On Chip Market Size 2027-2032 ($ millions)
Figure 67. Korea Organ On Chip Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia Organ On Chip Market Size 2027-2032 ($ millions)
Figure 69. India Organ On Chip Market Size 2027-2032 ($ millions)
Figure 70. Australia Organ On Chip Market Size 2027-2032 ($ millions)
Figure 71. Germany Organ On Chip Market Size 2027-2032 ($ millions)
Figure 72. France Organ On Chip Market Size 2027-2032 ($ millions)
Figure 73. UK Organ On Chip Market Size 2027-2032 ($ millions)
Figure 74. Italy Organ On Chip Market Size 2027-2032 ($ millions)
Figure 75. Russia Organ On Chip Market Size 2027-2032 ($ millions)
Figure 76. Egypt Organ On Chip Market Size 2027-2032 ($ millions)
Figure 77. South Africa Organ On Chip Market Size 2027-2032 ($ millions)
Figure 78. Israel Organ On Chip Market Size 2027-2032 ($ millions)
Figure 79. Turkey Organ On Chip Market Size 2027-2032 ($ millions)
Figure 80. Global Organ On Chip Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global Organ On Chip Market Size Market Share Forecast by End User (2027-2032)
Figure 82. GCC Countries Organ On Chip Market Size 2027-2032 ($ millions)